State-of-the-art of the high dose influenza vaccine in Spain - Takeaways - MDSpire

State-of-the-art of the high dose influenza vaccine in Spain

  • By

  • Iván Sanz-Muñoz

  • Manel Farre-Avella

  • Paulo J. Barroso-Santos

  • José M. Eiros

  • June 30, 2026

  • 0 min

Share

  • 1

    High-dose influenza vaccines are more effective than standard-dose vaccines in preventing severe outcomes in adults aged ≥60 years.

  • 2

    The introduction of high-dose vaccines in Spain has led to varied uptake across regions, with some prioritizing institutionalized populations.

  • 3

    Older adults, particularly those with comorbidities, face increased risks of severe influenza-related complications and mortality.

  • 4

    Influenza causes significant morbidity and mortality, particularly in individuals aged ≥65, with thousands of hospitalizations and deaths annually in Spain.

  • 5

    Evidence supports the broader adoption of high-dose influenza vaccines as a strategy to enhance protection for older adults.

Original Source(s)

State-of-the-art of the high dose influenza vaccine in Spain

  • by Iván Sanz-Muñoz, Manel Farre-Avella, Paulo J. Barroso-Santos, José M. Eiros

  • June 30, 2026

Related Content

Fatal European subtype tick-borne encephalitis in a fully vaccinated immunocompetent child: a case report with viral sequencing

Influenza Vaccination Trends Among Children and Adolescents, 2017-2023

Influenza Vaccine and Associated Infection and Death in California, 2024 to 2025